CAT #: 21030011
IGL Tube - 6FAM for ABI Fluorescence Detection
IGL Tube – 6FAM for ABI Fluorescence Detection is a Research Use Only master mix that can be used to identify immunoglobulin lambda (IGL) light chain gene rearrangements.
The human immunoglobulin lambda (IGL) light chain locus is located on the long arm of chromosome 22 (22q11.2) and spans 1050 kilobases. It is made up of 73-74 variable (Vλ) gene segments (spread over 900 kilobases), 7-11 joining (Jλ) gene segments and 7-11 constant (Cλ) gene segments depending on the haplotypes. Of the 73-74 Vλ region genes, only 30-33 are functional and can be grouped into 11 families and 3 clans. The Jλ and Cλ region genes are organized in tandem with a Jλ segment preceding a Cλ gene. Typically there are seven (7) Jλ-Cλ segments of which four (4) are functional and encode the four (4) Ig lambda isotypes. Vλ-Jλ rearrangements potentially represent an attractive extra PCR target for clonality studies to compensate for false-negative IGH VH-JH PCR results mainly caused by somatic hypermutations.
The IGL Tube master mix targets conserved regions within the variable (Vλ1-3) and the joining (Jλ1-3) regions that flank the unique, hypervariable, antigen-binding, complementarity determining region 3 (CDR3). Clonality is indicated if the master mix generates clonal band(s). PCR products are differentially labeled with 6FAM and can be analyzed using any platform that has the ability to detect these fluorochromes.
Warranty and Liability
Invivoscribe, Inc. (Invivoscribe®) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe®. Invivoscribe® liability shall not exceed the purchase price of the product. Invivoscribe® shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of internally validated positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.
This product is for Research Use Only; not for use in diagnostic procedures.
©2023 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.